Risk of second primary cancer after Hodgkin's disease in patients in the British National Lymphoma Investigation: relationships to host factors, histology and stage of Hodgkin's disease, and splenectomy.

Ítems similars

• Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
  per: Swerdlow, A. J., et al.
  Publicat: (1992)
• Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases.
  per: Morton, J. E., et al.
  Publicat: (1993)
• Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
  per: Vaughan Hudson, B., et al.
  Publicat: (1994)
• Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation.
  per: Vaughan Hudson, B, et al.
  Publicat: (1987)
• Completeness of cancer registration in England and Wales: an assessment based on 2,145 patients with Hodgkin's disease independently registered by the British National Lymphoma Investigation.
  per: Swerdlow, A. J., et al.
  Publicat: (1993)